Meet the Greek: Innovations in Breast Cancer Care With Dr. Heather Parsons

In this episode of Meet the Greek, Dr. Heather Parsons discusses her journey in oncology, focusing on breast cancer. She highlights the importance of circulating tumor DNA in detecting cancer and guiding treatment decisions. The conversation also covers exciting clinical trials, the significance of multidisciplinary care, and the role of genetic testing in patient management. Dr. Parsons emphasizes the need for timely access to care and collaboration with community oncologists to improve patient outcomes. Looking ahead, she shares her vision for the future of breast cancer care at Fred Hutch Cancer Center. Takeaways Circulating tumor DNA can reveal cancer changes through a simple blood test. The technology surrounding circulating tumor DNA is rapidly evolving. Refining patient groups for therapy can enhance clinical trial efficiency. A recent study found 10% of patients had detectable DNA in their blood. Proactive symptom management is crucial in cancer care. Genetic testing is vital for personalized cancer treatment. Collaboration with community oncologists is essential for comprehensive care. The future of breast cancer care is promising with ongoing research and innovation.